<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03914521</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL19_0095</org_study_id>
    <nct_id>NCT03914521</nct_id>
  </id_info>
  <brief_title>Pre-surgical CT Scan Assessment of Bone Mineral Density Before Resection of NHO of the Hip</brief_title>
  <official_title>Pre-surgical CT Scan Assessment of Femoral Head Bone Mineral Density Before Resection of Neurogenic Heterotopic Ossification (NHO) of the Hip</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neurogenic heterotopic ossification (NHO) is defined as an ectopic ossification around
      proximal joints usually seen after traumatic brain injury, spinal cord injury or polytrauma.

      NHO causes pain, partial or total joint ankylosis and vascular or nerve complications.

      The osteopenia (low bone density) induced by ankylose increases the fracture risk of femoral
      neck during the hip surgery performed to remove the NHO.

      The analyse of femoral head bone mineral density from hip pre-surgical CT scan could
      anticipate this kind of complication establishing a presurgical prognostic.

      If as it turns out the bone density measured from hip pre-surgical CT scan is relevant
      fracture risk marker, a preventive osteosynthesis or femoral head and neck resection could be
      performed in the same time of NHO resection.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>femoral head bone mineral density</measure>
    <time_frame>1 year</time_frame>
    <description>femoral head bone mineral density</description>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Paraosteoarthropathies</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients having surgery resection of surgery resection of Neurogenic heterotopic
        ossification of hip.

        Their per-operative CT-scan and surgery report will be collected from the records of NÃ®mes
        and Montpellier University Hospital Center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18 years and over

          -  Patients having surgery resection of surgery resection of Neurogenic heterotopic
             ossification of hip.

          -  Patients with pre-surgery CT-scan and surgery report available

        Exclusion criteria:

          -  Minor patients

          -  Patients didn't have surgery surgery resection of Neurogenic heterotopic ossification
             of hip.

          -  Pre-surgery CT-scan and surgery report not available

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florence BAUMANN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 11, 2019</study_first_submitted>
  <study_first_submitted_qc>April 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hip surgery</keyword>
  <keyword>bone mineral density</keyword>
  <keyword>femoral head</keyword>
  <keyword>Pre-surgical prognostic</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

